Ex Parte DYKSTRA et al - Page 5


                 Appeal No. 2001-1051                                                         Page 5                    
                 Application No.  08/185,079                                                                            

                        Tidwell III at Col. 11, ll. 43-45 teaches that “[t]he results in Table 5 also                   
                 reveal that the inhibitor produced a slight but consistent decrease in the yield of                    
                 P-3 virus.”  That statement, however, relates to a single compound and a single                        
                 virus, and thus does not render the prior express teaching of Tidwell moot.  In                        
                 addition, the decrease is only slight, thus the above statement, when read with                        
                 the statement that the suppressive effect of the compound is virus specific,                           
                 would not motivate one of ordinary skill to use the compounds on another,                              
                 completely different virus, i.e., a retrovirus.                                                        
                        Vonderfecht does not remedy the deficiencies of the Tidwell references.                         
                 Vonderfecht teaches that one compound, BABIM, which falls within the claimed                           
                 genus of compounds, is the most potent synthetic, reversible inhibitor of trypsin                      
                 yet identified.  See Vonderfecht, page 2011, col. 2.  The reference also teaches                       
                 that BABIM restricts the intestinal replication of the murine of rotavirus when the                    
                 compound and the virus were administered simultaneously to suckling mice.                              
                 See Vonderfecht, abstract.  Finally, as relied upon by the examiner, Vonderfecht                       
                 also teaches:                                                                                          
                        In this instance, it was shown that BABIM delays viral penetration                              
                        into cells by its antiprotease action but does not interfere with viral                         
                        RNA replication.  Protease inhibitors such as the ones described in                             
                        this report represent a new class of viral agents that functions at                             
                        the level of protein interactions and would not be expected to have                             
                        such potential for long-term untoward effects on mammalian                                      
                        nucleic acids.  In addition, many pathogenic viruses, including                                 
                        myxoviruses, paramyxoviruses, retroviruses, coronaviruses, and                                  
                        poxviruses, require viral or host proteases for productive infection.                           
                        Thus, chemotherapeutic agents which possess protease inhibitory                                 
                        activity may have a broad range of antiviral activity.  The availability                        
                        of antiviral agents capable of inhibiting a wide range of pathogenic                            
                        viruses without interfering with host nucleic acid replication may                              





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007